Literature DB >> 31370010

Fetal surgery for spina bifida.

Michael C Dewan, John C Wellons.   

Abstract

The two-hit hypothesis of neural injury in the wake of open neural tube defects suggests an opportunity for preservation of function and potential reversibility of early morphological changes in the fetus diagnosed with myelomeningocele. The Management of Myelomeningocele Study (MOMS) demonstrated reduced need for shunting and improved neurological function in patients treated in utero relative to postnatally, thereby offering level 1 evidence supporting fetal repair. Subsequent studies have offered additional information about urological, orthopedic, radiological, and maternal factors surrounding fetal repair. The quest for robust long-term neurocognitive and motor function data is underway and poised to shape the future of fetal repair. In addition, technical innovations such as fetoscopic surgery aim to minimize maternal morbidity while conferring the beneficial effects observed with open intrauterine intervention.

Entities:  

Keywords:  CHOP = Children’s Hospital of Philadelphia; CM-II = Chiari malformation type II; CPC = choroid plexus cauterization; ETV = endoscopic third ventriculostomy; IUR = intrauterine repair; MM = myelomeningocele; MOMS = Management of Myelomeningocele Study; PROM = premature rupture of membranes; TCS = tethered cord syndrome; VP = ventriculoperitoneal; congenital; fMMR = fetal MM repair; fetal; fetoscopic; intrauterine; myelomeningocele; spina bifida

Mesh:

Year:  2019        PMID: 31370010     DOI: 10.3171/2019.4.PEDS18383

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  5 in total

1.  Special considerations in randomized trials investigating neonatal surgical treatments.

Authors:  Martin L Blakely; Matthew A Rysavy; Kevin P Lally; Barry Eggleston; Claudia Pedroza; Jon E Tyson
Journal:  Semin Perinatol       Date:  2022-06-10       Impact factor: 3.311

2.  Central and Peripheral Cannulation for Cardiopulmonary Bypass in Fetal Sheep: A Comparative Study.

Authors:  Yun Teng; Miao Tian; Bingxin Huang; Wentao Wu; Qiuping Jiang; Xiaokang Luo; Wei Pan; Jian Zhuang; Chengbin Zhou; Jimei Chen
Journal:  Front Cardiovasc Med       Date:  2021-12-13

Review 3.  The Unique Properties of Placental Mesenchymal Stromal Cells: A Novel Source of Therapy for Congenital and Acquired Spinal Cord Injury.

Authors:  Edwin S Kulubya; Kaitlin Clark; Dake Hao; Sabrina Lazar; Arash Ghaffari-Rafi; Tejas Karnati; Julius Okudu Ebinu; Marike Zwienenberg; Diana L Farmer; Aijun Wang
Journal:  Cells       Date:  2021-10-22       Impact factor: 6.600

4.  Intra-amniotic transplantation of brain-derived neurotrophic factor-modified mesenchymal stem cells treatment for rat fetuses with spina bifida aperta.

Authors:  Wei Ma; Xiaowei Wei; Hui Gu; Dan Liu; Wenting Luo; Songying Cao; Shanshan Jia; Yiwen He; Lizhu Chen; Yuzuo Bai; Zhengwei Yuan
Journal:  Stem Cell Res Ther       Date:  2022-08-13       Impact factor: 8.079

5.  Neural Stem Cell-Derived Exosomal Netrin1 Contributes to Neuron Differentiation of Mesenchymal Stem Cells in Therapy of Spinal Bifida Aperta.

Authors:  Ling Ma; Xiaowei Wei; Wei Ma; Yusi Liu; Yanfu Wang; Yiwen He; Shanshan Jia; Yu Wang; Wenting Luo; Dan Liu; Tianchu Huang; Jiayu Yan; Hui Gu; Yuzuo Bai; Zhengwei Yuan
Journal:  Stem Cells Transl Med       Date:  2022-05-27       Impact factor: 7.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.